Swiss National Bank Sells 900 Shares of Colgate-Palmolive (NYSE:CL)

Swiss National Bank lowered its stake in Colgate-Palmolive (NYSE:CL) by 0.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,314,400 shares of the company’s stock after selling 900 shares during the period. Swiss National Bank’s holdings in Colgate-Palmolive were worth $240,258,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in CL. Thrivent Financial for Lutherans lifted its position in shares of Colgate-Palmolive by 39.8% in the third quarter. Thrivent Financial for Lutherans now owns 90,023 shares of the company’s stock worth $9,345,000 after purchasing an additional 25,645 shares in the last quarter. Claro Advisors LLC boosted its stake in shares of Colgate-Palmolive by 6.6% in the third quarter. Claro Advisors LLC now owns 22,180 shares of the company’s stock valued at $2,303,000 after buying an additional 1,364 shares during the period. Concord Asset Management LLC VA increased its holdings in Colgate-Palmolive by 14.8% in the 3rd quarter. Concord Asset Management LLC VA now owns 12,371 shares of the company’s stock valued at $1,284,000 after buying an additional 1,598 shares during the period. Tower Bridge Advisors raised its holdings in shares of Colgate-Palmolive by 1.2% during the 3rd quarter. Tower Bridge Advisors now owns 26,137 shares of the company’s stock worth $2,713,000 after buying an additional 314 shares in the last quarter. Finally, Adero Partners LLC increased its holdings in shares of Colgate-Palmolive by 9.6% during the third quarter. Adero Partners LLC now owns 3,141 shares of the company’s stock worth $326,000 after buying an additional 275 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Trading Up 2.3 %

Colgate-Palmolive stock opened at $93.56 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The firm has a market cap of $76.44 billion, a PE ratio of 26.81, a P/E/G ratio of 3.34 and a beta of 0.42. The stock’s 50 day simple moving average is $99.31 and its two-hundred day simple moving average is $98.49. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Analyst Ratings Changes

CL has been the subject of several analyst reports. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Thursday. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price objective for the company. UBS Group boosted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Sanford C. Bernstein lifted their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.